Effect of public disclosure on antibiotic prescription rate for upper respiratory tract infections

JAMA Intern Med. 2015 Mar;175(3):445-7. doi: 10.1001/jamainternmed.2014.6569.

Authors

Jae Moon Yun¹, Dong Wook Shin¹, Seung-Sik Hwang², Juhee Cho³, You Seon Nam¹, Jung Hoe Kim⁴, Be Long Cho¹

Affiliations

¹ Health Promotion Center, Department of Family Medicine, Seoul National University Hospital, Seoul, Korea.
² Department of Social and Preventive Medicine, Inha University School of Medicine, Incheon, Korea.
³ Department of Health Sciences and Technology, Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University, Seoul, Korea.
⁴ Health Insurance Review & Assessment Service, Seoul, Korea.

PMID: 25506784
DOI: 10.1001/jamainternmed.2014.6569

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Disclosure*
Humans
Prescriptions / statistics & numerical data
Republic of Korea
Respiratory Tract Infections / drug therapy*
United States

Substances

Anti-Bacterial Agents